News for 'Cipla'

ASK AJIT: Stocks To Buy, Hold, Sell

ASK AJIT: Stocks To Buy, Hold, Sell

Rediff.com11 Mar 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.

5 more manufacturers to produce black fungus drug: Govt

5 more manufacturers to produce black fungus drug: Govt

Rediff.com21 May 2021

The Union health ministry on Friday said license has been given to five more manufacturers for production of Amphotericin-B, used in the treatment of black fungus, and they will start producing 1,11,000 vials of the drug per month from July.

At Rs 35 a pill, Sun Pharma's FluGuard is the cheapest favipiravir drug

At Rs 35 a pill, Sun Pharma's FluGuard is the cheapest favipiravir drug

Rediff.com5 Aug 2020

Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease.

'Time has now come to say GOODBYE to India'

'Time has now come to say GOODBYE to India'

Rediff.com11 Feb 2013

Interview with Chairman, Cipla.

US polls, Covid fears likely to impact stock markets this week

US polls, Covid fears likely to impact stock markets this week

Rediff.com1 Nov 2020

Stock markets are expected to remain under pressure this week due to the overhang of US presidential polls and uncertainty over global growth due to resurging cases of coronavirus, according to analysts.

Govt approves 2 new vaccines, Covid drug for emergency use

Govt approves 2 new vaccines, Covid drug for emergency use

Rediff.com28 Dec 2021

The announcement comes a day after the Subject Expert Committee (SEC) on COVID-19 of the CDSCO recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax with certain conditions.

Many India Inc biggies in Sebi's list of 2000 defaulters

Many India Inc biggies in Sebi's list of 2000 defaulters

Rediff.com4 Apr 2018

SBI Capital, Axis Capital, GMR Holdings, United Breweries, Alpic Finance (a Cipla group unit), Saradha Realty, United Bank of India and Trident India are among the prominent entities named in the list.

India's top 7 pharma companies

India's top 7 pharma companies

Rediff.com2 Jan 2008

Cipla tops pharma rankings with 5.42% market share, ahead of Ranbaxy and GSK.

Merck bid: Ranbaxy makes it to next round

Merck bid: Ranbaxy makes it to next round

Rediff.com16 Mar 2007

Ranbaxy is understood to have emerged as the sole Indian pharma entity to have moved into the next round of bidding for the generic business of Merck, even as compatriot Cipla claimed to be "very much in the race."

'Government of India should own responsibility of universal vaccination'

'Government of India should own responsibility of universal vaccination'

Rediff.com29 May 2021

'The vaccine policy should be such that all people should get the vaccine free.'

Big pharma disappoints, but growth on track

Big pharma disappoints, but growth on track

Rediff.com9 Feb 2011

India's largest pharma companies by market capitalisation Sun Pharma, Dr Reddy's and Cipla have seen their share prices drop 5-20 per cent over the last two weeks on results that were below Street expectations.

Delta plus: New Covid variant identified in India

Delta plus: New Covid variant identified in India

Rediff.com14 Jun 2021

The highly transmissible Delta variant of SARS-CoV-2 has mutated further to form the 'Delta plus' or 'AY.1' variant but there is no immediate cause for concern in India as its incidence in the country is still low, scientists in New Delhi said.

Delhi HC extends relief to pharma firms in drug ban case

Delhi HC extends relief to pharma firms in drug ban case

Rediff.com21 Mar 2016

Several companies, including Indian units of Abbott Laboratories and Pfizer Inc, and domestic firms like Cipla Ltd and Macleods Pharmaceuticals, went to the Delhi High Court to try to get the ban lifted.

Ranbaxy loses exclusivity on heartburn drug in US

Ranbaxy loses exclusivity on heartburn drug in US

Rediff.com28 Jan 2015

FDA allows Teva to launch Nexium generic; Cipla, which supplies formulation, to gain

6 major companies found manufacturing 'substandard' drugs

6 major companies found manufacturing 'substandard' drugs

Rediff.com18 May 2016

Alkem Labs was issued drug alerts twice last year -- in June and July -- for its drug Glimekem.

Prices of key Covid bulk drugs shoot up as demand rises

Prices of key Covid bulk drugs shoot up as demand rises

Rediff.com12 May 2021

The API of Paracetamol, a fever and pain medication, has grown 25 per cent from Rs 450-480 per kg in December 2020 to Rs 580-600 per kg in April. When compared to the pre-Covid prices of December 2019, the surge is much steeper -- around 140 per cent, reports Sohini Das.

Why 60% of large-cap schemes underperformed the Nifty100 index in CY20

Why 60% of large-cap schemes underperformed the Nifty100 index in CY20

Rediff.com4 Jan 2021

Polarisation and the increase in index weight of a few a stocks have weighed on performance. The worst performers include Nippon India Large Cap and HDFC Top 100 (2.6 per cent).

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Rediff.com13 Jun 2016

The combined sales of the branded versions of the products in the US is about $3.5 billion.

36 drugs to be cheaper as govt caps prices

36 drugs to be cheaper as govt caps prices

Rediff.com19 Sep 2014

India has capped the prices of 36 drugs, including those used to treat infections and diabetes, in its latest move to make essential medicines more affordable, a senior official of the country's drug pricing authority told Reuters on Friday.

Domestic firms to supply AIDS drug

Domestic firms to supply AIDS drug

Rediff.com5 May 2008

Domestic drug makers Cipla, Aurobindo and Matrix Laboratories have emerged as the second-line and paediatric AIDS medicine supply partners to international drug purchase facility UNITAID and Clinton Foundation HIV / AIDS Initiative in 2008. UNITAID and CHAI support HIV / AIDS treatment programmes in over 100 countries worldwide.

As domestic sales decline, drug makers focus on exports

As domestic sales decline, drug makers focus on exports

Rediff.com1 Oct 2020

While sales in the domestic market declined 4.2 per cent during the April-July period, exports grew steadily at 9.5 per cent during the same period.

ASK AJIT: Stocks To Buy, Sell, Hold

ASK AJIT: Stocks To Buy, Sell, Hold

Rediff.com24 Jan 2022

Ajit Mishra, vice president, research, Religare Broking, answers your queries.

Family-owned companies weathering Covid-19 pandemic storm better

Family-owned companies weathering Covid-19 pandemic storm better

Rediff.com10 Sep 2020

Such businesses outperform non-family firms by 3% in first six months of CY20, says Credit Suisse report.

India battles big pharma over cough syrup abuse, reducing supplies

India battles big pharma over cough syrup abuse, reducing supplies

Rediff.com14 Oct 2015

India battles big pharma over cough syrup abuse, reducing supplies

Do you own these stocks? EXIT them NOW

Do you own these stocks? EXIT them NOW

Rediff.com22 Sep 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Rediff.com12 Feb 2020

Indian pharmaceutical companies are heavily dependent on China to source fermentation-based active pharmaceutical ingredients and intermediates to manufacture these medicines, but the coronavirus outbreak there has disrupted the supply.

Nearly 50% BSE 500 stocks underperform market since March low

Nearly 50% BSE 500 stocks underperform market since March low

Rediff.com25 Sep 2020

The S&P BSE 500 index, which accounts for 94% market capitalisation of BSE listed companies, has gained 45% from its March 24 low. However, out of the BSE 500 index stocks, 225 have underperformed the index by gaining less than the broader index during this period.

Ask Ajit: Stocks to Buy, Hold or Exit

Ask Ajit: Stocks to Buy, Hold or Exit

Rediff.com21 Jun 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Adverse effect of Covid-19 vaccine: What the law says

Adverse effect of Covid-19 vaccine: What the law says

Rediff.com15 Jan 2021

Laws governing compensation in case of adverse side effects for Covaxin and Covishield may differ in accordance with the kind of approvals given, say legal experts.

Is India's war against multinational corporations justified?

Is India's war against multinational corporations justified?

Rediff.com28 Mar 2014

The realisation has struck people that multinationals have been doing all those things that Indian businessmen have long been accused of doing.

Ask Ajit: 'Want to invest Rs 2 lakhs, please advise'

Ask Ajit: 'Want to invest Rs 2 lakhs, please advise'

Rediff.com22 Nov 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Stocks to create long-term wealth

Stocks to create long-term wealth

Rediff.com25 Sep 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Wockhardt, Novartis mum on patent issue

Wockhardt, Novartis mum on patent issue

Rediff.com24 Jun 2005

Two pharma majors Novartis and Wockhardt have adopted 'wait and watch' policy with regard to opposition over the yet to be granted patent to their respective drugs.

100% placements for IIM-Lucknow graduates

100% placements for IIM-Lucknow graduates

Rediff.com23 Oct 2017

Irrespective of demonetisation and GST blues, IIM Lucknow has been able to successfully place their batch of 459 students.

Expert advice: Avoid these stocks and IPOs

Expert advice: Avoid these stocks and IPOs

Rediff.com1 Aug 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

'Dear Ajit: Need your advice on mid- and small-caps'

'Dear Ajit: Need your advice on mid- and small-caps'

Rediff.com30 Jul 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

ASK AJIT: 'Want to invest Rs 20 lakh in 10-12 stocks'

ASK AJIT: 'Want to invest Rs 20 lakh in 10-12 stocks'

Rediff.com25 Feb 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Top Indian generic drug makers look to US as patents end

Top Indian generic drug makers look to US as patents end

Rediff.com9 May 2013

They seek to profit from big-selling drugs going off-patent this year in the lucrative market.

Record spike in deaths as India COVID-19 tally tops 4.25 lakh

Record spike in deaths as India COVID-19 tally tops 4.25 lakh

Rediff.com23 Jun 2020

As the death toll in the country from coronavirus jumped by a record 445 to 13,699, the Centre maintained that the number of infections per lakh population was among the lowest in the world. The new cases surged by over 10,000 for the 11th day in a row and rose by 14,821 to take the total to 4,25,282, according to health ministry data.